<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-2397</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОТ РЕДАКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FROM EDITOR</subject></subj-group></article-categories><title-group><article-title>Ионные хроматографы L-Ion марки SILab для контроля качества на фармацевтических предприятиях</article-title><trans-title-group xml:lang="en"><trans-title>SILab L-Ion ion chromatographs for quality control in pharmaceutical companies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рекламная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Sponsored</surname><given-names>Article</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>11</day><month>06</month><year>2026</year></pub-date><volume>15</volume><issue>2</issue><fpage>29</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рекламная с., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Рекламная с.</copyright-holder><copyright-holder xml:lang="en">Sponsored a.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/2397">https://www.pharmjournal.ru/jour/article/view/2397</self-uri><abstract><p>Метод ионной или ионообменной хроматографии (ИХ), несмотря на несколько меньшую популярность, чем традиционная ВЭЖХ, также активно применяется для контроля качества препаратов и субстанций в фармацевтической промышленности. Чаще всего целевыми соединениями являются неорганические ионы, однако ИХ также применяют для разделения органических кислот, сахаров, аминогликозидов, аминокислот и пр.</p></abstract><trans-abstract xml:lang="en"><p>Ion or ion-exchange chromatography (IC), although somewhat less popular than traditional HPLC, is also widely used for quality control of drugs and substances in the pharmaceutical industry. Most often, the target compounds are inorganic ions, but IC is also used to separate organic acids, sugars, aminoglycosides, amino acids, and other substances.</p></trans-abstract><funding-group><funding-statement xml:lang="ru">Авторы подготовили статью при финансовой поддержке  компании ООО «Лабконцепт»</funding-statement><funding-statement xml:lang="en">The authors prepared the article with the financial support of  the company LLC "Labconcept"</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
